Vol. 12 No. 2 (2024)
Published:
2024-08-13
Articles
-
Abstract views: 263https://doi.org/10.61096/ijphr.v12.iss2.2024.159-171
-
Abstract views: 347https://doi.org/10.61096/ijphr.v12.iss2.2024.80-83
-
Abstract views: 185https://doi.org/10.61096/ijphr.v12.iss2.2024.149-158
-
Abstract views: 437https://doi.org/10.61096/ijphr.v12.iss2.2024.144-148
-
Abstract views: 609https://doi.org/10.61096/ijphr.v12.iss2.2024.130-143
-
Formulation Development And In Vitro Characterisation Of Deflazacort Extended Release Matrix TabletsAbstract views: 439https://doi.org/10.61096/ijphr.v12.iss2.2024.118-129
-
Abstract views: 239https://doi.org/10.61096/ijphr.v12.iss2.2024.107-117
-
Abstract views: 188https://doi.org/10.61096/ijphr.v12.iss2.2024.96-106
-
Abstract views: 245https://doi.org/10.61096/ijphr.v12.iss2.2024.84-95
-
Formulation Development And In Vitro Characterisation Of Deflazacort Extended Release Matrix TabletsAbstract views: 254https://doi.org/10.61096/ijphr.v12.iss2.2024.73-79
-
Abstract views: 213https://doi.org/10.61096/ijphr.v12.iss2.2024.64-72
-
Abstract views: 474https://doi.org/10.61096/ijphr.v12.iss2.2024.55-63
-
Abstract views: 491https://doi.org/10.61096/ijphr.v12.iss2.2024.35-45
-
Abstract views: 356https://doi.org/10.61096/ijphr.v12.iss2.2024.26-34
